Research for Amyloid PET-MRI

Not Applicable

• Conditions: Healthy volunteer, Alzheimer' s disease, Mild cognitive impairment, Parkinson' s disease, PD

• Registration Number: JPRN-UMIN000040338
• Lead Sponsor: Kyoto University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-01
• Last Update Posted: 17 October 2023
• Study Completion: 2026-03-31

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Not provided

Exclusion Criteria

1. Other neurodegenerative disease, multiple brain infarction, normal pressure hydrocephalus, brain tumor, epilepsy, subdural hematoma, multiple sclerosis, and brain contusion. 2. Specific abnormal findings on brain MRI. 3. drug induced parkinsonism 4. SWEDD 5. Metalic implants 6. Allergy to 123I-FP-CIT 7. Depression, schizophrenia 8. Alcohol or drug addicts 9. Psychological disorder 10. Severe systemic disease 11. Infection, metabolic disorders 12. Those who are hospitalized in nursing homes. 13. Those who participated in other clinical researches. 14. Those who will be scheduled to participate in other clinical researches. 15. Other reasons considered by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Standardized uptake value at PET/CT and PET/MRI